This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Never start, stop, or change medication without consulting your prescribing physician. Every person responds differently to medication.
UpOrbit has no financial relationship with Takeda or any pharmaceutical company. No affiliate links on this page.
Vyvanse (lisdexamfetamine) is a long-acting stimulant medication prescribed for ADHD in adults and children. It is a prodrug, meaning it is inactive until your body converts it into dextroamphetamine, which produces a smoother onset and lower misuse potential compared to other stimulants.
What makes Vyvanse different
Vyvanse (lisdexamfetamine dimesylate) is a prodrug — meaning it's pharmacologically inactive until your body converts it. The lisdexamfetamine molecule is dextroamphetamine bonded to the amino acid L-lysine. After you swallow it, enzymes in your red blood cells gradually cleave the lysine, releasing active dextroamphetamine into your bloodstream.
This prodrug design has two important consequences:
- Smoother onset and offset: Because conversion happens gradually, Vyvanse produces a more consistent blood level of active medication compared to Adderall IR, which delivers the full dose at once.
- Lower misuse potential: Crushing, snorting, or injecting Vyvanse doesn't accelerate the conversion — the enzymatic process still takes time. It is still a Schedule II controlled substance, like other amphetamines, but the prodrug design lowers its abuse liability. Jasinski & Krishnan (2009) demonstrated that IV lisdexamfetamine produced significantly lower "drug liking" scores compared to equivalent doses of d-amphetamine.
Vyvanse was FDA-approved for ADHD in 2007 and is manufactured by Takeda. Generic lisdexamfetamine became available in the US in August 2023.
How it works in the brain
Once converted, the active component is pure dextroamphetamine — the same compound that makes up part of Adderall. It increases dopamine and norepinephrine availability in the prefrontal cortex through the same mechanisms: transporter reversal, vesicular release, and weak MAO inhibition.
The key pharmacokinetic difference is the absorption curve. Ermer et al. (2010) showed that Vyvanse produces peak d-amphetamine levels (Tmax) about 3.5 hours after a capsule dose in children and about 3.8 hours in adults (FDA label). Adderall XR's overall Tmax is about 7 hours per its FDA label, because of its delayed-release beads. The gradual conversion creates what many patients and clinicians describe as a "gentler" on-ramp.
Duration of clinical effect is typically 10–14 hours, though individual variation is significant. Some people report consistent coverage for 12+ hours; others find it fades closer to 8–10 hours.
Clinical evidence
The Cortese et al. (2018) network meta-analysis in The Lancet Psychiatry included lisdexamfetamine in its analysis and found amphetamine-class medications (including Vyvanse) to be the most effective pharmacological treatment for adult ADHD.
A pivotal trial by Adler et al. (2008) demonstrated that lisdexamfetamine produced statistically significant improvement in ADHD symptoms compared to placebo across all doses studied (30mg, 50mg, 70mg) in a 4-week randomized controlled trial of adults.
Coghill et al. (2013) conducted a randomized, three-arm trial comparing lisdexamfetamine, methylphenidate (Concerta), and placebo in children and adolescents, finding that lisdexamfetamine showed greater symptom reduction than both methylphenidate and placebo.
"Why do I lose track of time on Vyvanse?"
This is one of the most commonly searched questions about Vyvanse. People describe becoming so absorbed in a task that hours pass without awareness — and they're confused because they thought the medication was supposed to help with time blindness.
What's likely happening is hyperfocus facilitated by improved dopamine signaling. The medication increases the brain's ability to sustain attention — but it doesn't automatically direct that attention to the right things. Your interest-based nervous system may lock onto whatever is engaging, and the improved focus makes it harder to break away.
Practical strategies: use external timers (like UpOrbit's focus timer), set alarms for transitions, and use the first 30 minutes of medication onset — before deep focus kicks in — to set up your day's structure. See our full article on this.
Dose-by-dose: what each strength typically does
Vyvanse is available in 10, 20, 30, 40, 50, 60, and 70 mg capsules. Dosing is individual. These are general clinical patterns:
| Dose | Typical Clinical Use | Active d-Amphetamine |
|---|---|---|
| 10-20 mg | Starting dose. Used to assess tolerability. Many adults feel minimal effect here. | ~3-5.9 mg |
| 30 mg | Common first therapeutic dose for adults. Focus improvement often first noticeable here. | ~8.9 mg |
| 40 mg | Mid-range. Solid focus with manageable side effects for most responders. | ~11.8 mg |
| 50 mg | Common adult therapeutic dose. Often the sweet spot in titration studies. | ~14.8 mg |
| 60 mg | Higher range. Appetite and sleep management become more important. | ~17.7 mg |
| 70 mg | Maximum recommended dose. Reserved for those who need and tolerate it. | ~20.7 mg |
The "active d-amphetamine" column shows how much dextroamphetamine is actually released after enzymatic conversion. This is useful for understanding dose equivalence with Adderall - see the equivalence table in that article.
Dose conversions are done by your prescriber, not by you — don't switch or adjust doses on your own.
Titration typically starts at 30mg and increases by 10-20mg weekly until optimal response. The goal is the lowest effective dose, not the highest tolerable one.
Common side effects
Side effects documented in clinical trials (percentages from prescribing information):
- Decreased appetite: 27% of adults, 39% of children ages 6-12, and 34% of adolescents ages 13-17 (vs. 2-4% on placebo). The most commonly reported side effect. Strategies: eat a substantial breakfast before the medication kicks in, plan calorie-dense snacks, eat a larger dinner when appetite returns. See medication and food.
- Insomnia: 27% of adults in clinical trials. Generally less disruptive than Adderall IR afternoon dosing because there's no second peak — the medication tapers gradually. See sleep strategies.
- Dry mouth: 26% of adults.
- Increased heart rate: Average increase of about 3–6 bpm across CNS stimulants (FDA label). Cardiovascular monitoring is standard practice; report palpitations or chest pain to your prescriber.
- The medication "wearing off": Some people experience a noticeable transition as Vyvanse effects diminish. This tends to be less abrupt than with IR formulations. See when meds wear off.
Interactions and considerations
- Vitamin C supplements: The label lists ascorbic acid as an acidifying agent that can lower amphetamine blood levels; tell your prescriber if you take it regularly. Orange juice is different: the label reports that it does not change dextroamphetamine levels. See our food rules by medication.
- Cannabis: May blunt medication benefits and complicate clinical monitoring. See ADHD and cannabis.
- Alcohol: Vyvanse may mask alcohol's sedative effects. See ADHD and alcohol.
- Caffeine: Additive stimulant effects. Some people reduce caffeine intake after starting Vyvanse; others continue without issue. See coffee and ADHD meds.
- MAOIs: Contraindicated, same as all amphetamines.
Dosing
Vyvanse is available in capsules: 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 70mg. Also available as a chewable tablet. Per the FDA label, the capsule can be opened and the entire contents mixed with yogurt, water, or orange juice and taken right away, for those who have difficulty swallowing pills. This doesn't alter the prodrug mechanism.
Typical starting dose for adults is 30mg. Titration usually proceeds in 10–20mg increments at weekly intervals. Maximum recommended dose is 70mg/day.
Frequently asked questions
How long does Vyvanse last?
Vyvanse typically provides 10 to 14 hours of clinical effect, though individual variation is significant. Some people report 12+ hours of coverage while others find it closer to 8 to 10 hours. The prodrug mechanism creates a gradual onset and offset rather than a sharp on/off cycle.
Is generic Vyvanse available?
Yes. Generic lisdexamfetamine became available in the US in August 2023. Cash prices vary widely by pharmacy, so checking discount programs can save significantly.
Can you open Vyvanse capsules?
Yes. Unlike many extended-release medications, Vyvanse capsules can be opened and the entire contents mixed with yogurt, water, or orange juice, then taken right away (per the FDA label). This does not alter the prodrug mechanism because the gradual release depends on enzymatic conversion in the body, not the capsule design.
Why do I lose track of time on Vyvanse?
Vyvanse increases the brain's ability to sustain attention, but it does not automatically direct that attention. Your interest-based nervous system may lock onto whatever is engaging, and the improved focus can make it harder to break away. External timers and transition alarms help manage this.
What is the difference between Vyvanse and Adderall?
Vyvanse is a prodrug that must be converted by enzymes in the body before becoming active dextroamphetamine. This creates a smoother onset and lower misuse potential compared to Adderall, which delivers active amphetamine salts directly. Vyvanse also tends to last longer (10 to 14 hours vs 4 to 6 for Adderall IR or 8 to 12 for Adderall XR).
Does Vyvanse cause weight loss?
Decreased appetite is the most common side effect, reported in 27% of adults in clinical trials. This can lead to weight loss, especially in the first few months. Strategies include eating a substantial breakfast before the medication takes effect, planning calorie-dense snacks, and eating a larger dinner when appetite returns.
Is Vyvanse better than Adderall?
Neither is universally better. Both are amphetamine-based stimulants, but Vyvanse is a prodrug with smoother onset and longer duration. Some people respond better to one than the other, and only a trial with your prescriber can tell which suits you. The best medication is whichever one your brain responds to with the fewest side effects.
References
- Cortese et al. (2018). Comparative efficacy of ADHD medications. The Lancet Psychiatry, 5(9), 727-738.
- Jasinski & Krishnan (2009). Abuse liability of lisdexamfetamine. J Psychopharmacol, 23(4).
- Ermer et al. (2010). Lisdexamfetamine pharmacokinetics. Clin Drug Investig, 30(1).
- Adler et al. (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with ADHD. J Clin Psychiatry, 69(9), 1364-1373.
- Vyvanse prescribing information. Takeda Pharmaceuticals. FDA label (DailyMed).
- Coghill et al. (2013). LDX vs methylphenidate in children. Eur Neuropsychopharmacol, 23(10).